6-K

AURINIA PHARMACEUTICALS INC. 6-K

Company: Aurinia Pharmaceuticals Inc.
Filed: November 8, 2018
Period of Report: November 8, 2018
Accession Number: 0001157523-18-002387

View Document ↗ View on SEC.gov ↗